Flanders Vaccine is a strategy-driven non-profit organisation, supporting the development of immunotherapeutics and vaccines for both prophylactic and therapeutic targets in humans and animals by facilitating the exchange of know-how and complementary innovative technologies between academia and industry.
The Flanders Vaccine platform can be seen as an integrated tool that gives rise to more and better partnerships; that prepares us better for future calls for funding; that enables us to network at inspiring meetings and conferences; that generates visibility and attracts significant attention from national and international experts, stakeholders and organisations.
Company Details
- Employees
- 5
- Founded
- 2016
- Address
- Agoralaan Building Abis, Diepenbeek,limburg 3590,belgium
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- flandersvaccine.be
- Keywords
- vaccines, immunology, immunotherapy.
- HQ
- Diepenbeek, Limburg
- Competitors
- IDEVAX, invoX, Biovia, pharma.be, SwiftPharma, simAbs, BioWin, Sciensano, P95, CESPE.
Flanders Vaccine Questions
Flanders Vaccine's website is flandersvaccine.be
Flanders Vaccine's LinkedIn profile is https://be.linkedin.com/company/flanders-vaccine
Flanders Vaccine has
5 employees.
View email and phone details for 5
employees at Flanders Vaccine.
Flanders Vaccine's industry is
Biotechnology Research
Flanders Vaccine's categories are Biotechnology Research
Flanders Vaccine's founding year is 2016
